IRB stung by investigation shuts down
NEWS IN BRIEF — Posted May 25, 2009
Coast IRB said in late April that it would be "ceasing all operations in the near future," staying open only to facilitate the transfer of its clients to other IRBs. Coast is under FDA suspension as a result of the GAO investigation.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2009/05/25/prbf0525.htm.